Trial Profile
Efficacy and Safety of Everolimus in Patients with Non-Clear Cell Renal Cell Carcinoma
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 04 Oct 2011 New trial record